Literature DB >> 10068670

Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation.

R Yabkowitz1, S Meyer, T Black, G Elliott, L A Merewether, H K Yamane.   

Abstract

Activation of endothelial cells, important in processes such as angiogenesis, is regulated by cell surface receptors, including those in the tyrosine kinase (RTK) family. Receptor activity, in turn, can be modulated by phosphorylation, turnover, or proteolytic release of a soluble extracellular domain. Previously, we demonstrated that release of soluble tie-1 receptor from endothelial cells by phorbol myristate acetate (PMA) is mediated through protein kinase C and a Ca2+-dependent protease. In this study, the release of soluble tie-1 was shown to be stimulated by inflammatory cytokines and vascular endothelial growth factor (VEGF), but not by growth factors such as basic fibroblast growth factor (bFGF) or transforming growth factor alpha (TGFalpha). Release of soluble tie by tumor necrosis factor alpha (TNFalpha) or VEGF occurred within 10 minutes of stimulation and reached maximal levels within 60 minutes. Specificity was shown by fluorescence-activated cell sorting (FACS) analysis; endothelial cells exhibited a significant decrease in cell surface tie-1 expression in response to TNF, whereas expression of epidermal growth factor receptor (EGF-R) and CD31 was stable. In contrast, tie-1 expression on megakaryoblastic UT-7 cells was unaffected by PMA or TNFalpha. Sequence analysis of the cleaved receptor indicated that tie-1 was proteolyzed at the E749/S750 peptide bond in the proximal transmembrane domain. Moreover, the hydroxamic acid derivative BB-24 demonstrated dose-dependent inhibition of cytokine-, PMA-, and VEGF-stimulated shedding, suggesting that the tie-1 protease was a metalloprotease. Protease activity in a tie-1 peptide cleavage assay was (1) associated with endothelial cell membranes, (2) specifically activated in TNFalpha-treated cells, and (3) inhibited by BB-24. Additionally, proliferation of endothelial cells in response to VEGF, but not bFGF, was inhibited by BB-24, suggesting that the release of soluble tie-1 receptor plays a role in VEGF-mediated proliferation. This study demonstrated that the release of soluble tie-1 from endothelial cells is stimulated by inflammatory cytokines and VEGF through the activation of an endothelial membrane-associated metalloprotease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068670

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

Review 1.  Molecular and cellular mechanisms of ectodomain shedding.

Authors:  Kazutaka Hayashida; Allison H Bartlett; Ye Chen; Pyong Woo Park
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

2.  Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions.

Authors:  N Chandrasekar; S Jasti; W K Alfred-Yung; F Ali-Osman; D H Dinh; W C Olivero; M Gujrati; A P Kyritsis; G L Nicolson; J S Rao; S Mohanam
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown.

Authors:  Shuntaro Ogura; Kaori Kurata; Yuki Hattori; Hiroshi Takase; Toshina Ishiguro-Oonuma; Yoonha Hwang; Soyeon Ahn; Inwon Park; Wataru Ikeda; Sentaro Kusuhara; Yoko Fukushima; Hiromi Nara; Hideto Sakai; Takashi Fujiwara; Jun Matsushita; Masatsugu Ema; Masanori Hirashima; Takashi Minami; Masabumi Shibuya; Nobuyuki Takakura; Pilhan Kim; Takaki Miyata; Yuichiro Ogura; Akiyoshi Uemura
Journal:  JCI Insight       Date:  2017-02-09

4.  Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice.

Authors:  Xianghu Qu; Kevin Tompkins; Lorene E Batts; Mira Puri; H Scott Baldwin; Scott Baldwin
Journal:  Development       Date:  2010-03-10       Impact factor: 6.868

Review 5.  Angiogenesis and the unique nature of tumor matrix.

Authors:  Vincenzo Chiarug; Marco Ruggiero; Lucia Magnelli
Journal:  Mol Biotechnol       Date:  2002-05       Impact factor: 2.695

Review 6.  Role of Tie1 in shear stress and atherosclerosis.

Authors:  Kel Vin Woo; H Scott Baldwin
Journal:  Trends Cardiovasc Med       Date:  2011-05       Impact factor: 6.677

Review 7.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

8.  The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.

Authors:  J Huang; K Chen; J Chen; W Gong; N M Dunlop; O M Z Howard; Y Gao; X-w Bian; J M Wang
Journal:  Br J Cancer       Date:  2010-03-02       Impact factor: 7.640

9.  Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2.

Authors:  Francesca Gotsch; Roberto Romero; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Michael Dombrowski; Offer Erez; Nandor Gabor Than; Shali Mazaki-Tovi; Pooja Mittal; Jimmy Espinoza; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-06

10.  Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface.

Authors:  Tania M Hansen; Harprit Singh; Tariq A Tahir; Nicholas P J Brindle
Journal:  Cell Signal       Date:  2010-03       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.